Article thumbnail

CD4+ T cells spontaneously producing human immunodeficiency virus type I in breast milk from women with or without antiretroviral drugs

By Diane Valea, Edouard Tuaillon, Yassine Al Tabaa, François Rouet, Pierre-Alain Rubbo, Nicolas Meda, Vincent Foulongne, Karine Bollore, Nicolas Nagot, Philippe Van de Perre and Jean-Pierre Vendrell
Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2003). A: Breast milk and HIV-1: vector of transmission or vehicle of protection? Lancet Infect Dis
  2. (2008). AD: Studies on antiretroviral drug concentrations in breast milk: validation of a liquid chromatography-tandem mass spectrometric method for the determination of 7 anti 628 human immunodeficiency virus medications. Ther Drug Monit
  3. (2003). al: Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of
  4. (2005). Aldrovandi GM: Breast milk-derived antigen-specific CD8+ T cells: an extralymphoid effector memory cell population in humans.
  5. (1992). AS: Activated and memory T lymphocytes in human milk. Cytometry
  6. (2004). Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission.
  7. (2005). Bomsel M: HIV-1-infected blood mononuclear cells form an integrin- and agrin-dependent viral synapse to induce efficient HIV-1 transcytosis across epithelial cell monolayer. Mol Biol Cell
  8. (1998). Cell-free human immunodeficiency virus type 1 in breast milk.
  9. (2000). Coovadia HM: Cell-free virus in breast milk of HIV-1-seropositive women. J Acquir Immune Defic Syndr
  10. (1977). Covelli HD: Evidence for transmission of lymphocyte responses to tuberculin by breast-feeding. Lancet
  11. (2006). de Perre P: Detection of a large T-cell reservoir able to replicate HIV-1 actively in breast milk. Aids
  12. (2000). Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infection. Aids
  13. (1982). DK: Distribution of T lymphocyte subsets in human colostrum.
  14. (2003). DR: Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial. Lancet
  15. (2009). E, et al: Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization. Clin Vaccine Immunol
  16. (2000). Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. Jama
  17. (2004). Effect of perinatal zidovudine prophylaxis on the evolution of cell-free HIV-1 RNA in breast milk and on postnatal transmission.
  18. (2007). Epidemic Update. Geneva
  19. (2008). et al: Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
  20. (2008). et al: Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India and Uganda: an analysis of three randomised controlled trials. Lancet
  21. (2005). et al: HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir.
  22. (2004). et al: Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis.
  23. (2003). Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals. Proc Natl Acad Sci USA
  24. (2005). Highly active antiretroviral therapy started during pregnancy or postpartum Valea et al.
  25. (2008). HIV-1 persists in breast milk cells despite antiretroviral treatment to prevent mother-to-child transmission. Aids
  26. (2002). Hocini H: Compartmentalization of HIV-1 between breast milk and blood of HIV-infected mothers. Virology
  27. (1993). Infective and anti-infective properties of breastmilk from HIV-1-infected women. Lancet
  28. (2005). JA: A randomized trial of two postexposure prophylaxis regimens to reduce mother to-child HIV-1 transmission in infants of untreated mothers. Aids
  29. (2003). JK: Breast-milk infectivity in human immunodeficiency virus type 1-infected mothers.
  30. (1980). JK: T lymphocytes in colostrum and peripheral blood differ in their capacity to form thermostable E rosettes.
  31. (2001). Kreiss JK: Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections.
  32. (2003). Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease.
  33. (1993). MA: Quantitation of human immunodeficiency virus type 1 infection kinetics.
  34. (2002). Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma.
  35. (2004). ML: Breast-feeding and Transmission of HIV-1. J Acquir Immune Defic Syndr
  36. (2004). Mother-to-child transmission of HIV-1: advances and controversies of the twentieth centuries. AIDS Rev
  37. (1999). Mother-to-child transmission of HIV-1: the ‘all mucosal’ hypothesis as a predominant mechanism of transmission. Aids
  38. (1978). Ogra PL: Immunologic aspects of human colostrum and milk. I. Distribution characteristics and concentrations of immunoglobulins at different times after the onset of lactation.
  39. (1977). Significance of the cellular component of the maternal immunologic endowment in milk. Transplant Proc
  40. (2008). Siliciano RF: Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection.
  41. (1999). Sokoll LJ, et al: Human immunodeficiency virus load in breast milk, mastitis, and mother-tochild transmission of human immunodeficiency virus type 1. J Infect Dis
  42. (2003). SZ: Postnatal transmission of HIV-1 after a maternal short course zidovudine peripartum regimen in West Africa. Aids
  43. (1997). TC: Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature
  44. (2003). Team KBS: Prevention of mother-to-child transmission of HIV-1 among breastfeeding mothers using HAART: the Kisumu breastfeeding study,
  45. (2011). The Kesho Bora Study Group: Triple-antiretroviral prophylaxis during pregnancy and breastfeeding compared to short-ARV prophylaxis to prevent mother-to-child transmission of HIV-I: the Kesho Bora randomized controlled clinical trial. Lancet Infect Dis
  46. (2007). The measurement of HIV-1 viral load in resourcelimited settings: how and where? Clin Lab
  47. (2006). Transmission of cell-free and cell-associated HIV-1 through breast-feeding. J Acquir Immune Defic Syndr
  48. (2002). Transmission of HIV-1 through breastfeeding among women in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr
  49. (2004). Vendrell JP: Human immunodeficiency virus type 1 (HIV-1) antigen secretion by latently infected resting CD4+ T lymphocytes from HIV-1-infected individuals.
  50. (2009). Vendrell JP: Human milk-derived B cells: a highly activated switched memory cell population primed to secrete antibodies.
  51. (2007). Vendrell JP: Isolation and characterization of HIV-1-infected resting CD4+ T lymphocytes in breast milk.
  52. (2007). Vendrell JP: Unintegrated HIV-1 provides an inducible and functional reservoir in untreated and highly active antiretroviral therapytreated patients. Retrovirology
  53. (1999). Wolinsky SM: Persistence of HIV-1 transcription in peripheralblood mononuclear cells in patients receiving potent antiretroviral therapy.